Israeli infant receives pioneering brain gene therapy for WOREE syndrome

1 min read
Source: The Jerusalem Post
Israeli infant receives pioneering brain gene therapy for WOREE syndrome
Photo: The Jerusalem Post
TL;DR Summary

An eight‑month‑old in Israel became the world’s first patient to receive an experimental brain gene‑replacement therapy aimed at restoring WWOX function to treat WOREE syndrome, delivered directly into the brain via an AAV9 vector at Schneider Children’s Medical Center. The procedure followed years of research led by Prof. Rami Aqeilan and supported by Mahzi Therapeutics; one month after treatment the baby was stable, had no seizures, and was discharged, but long‑term safety and efficacy require ongoing follow‑up.

Share this article

Reading Insights

Total Reads

0

Unique Readers

19

Time Saved

15 min

vs 16 min read

Condensed

97%

3,02877 words

Want the full story? Read the original article

Read on The Jerusalem Post